Ziyue Sha
Shijiazhuang, 050000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer.
Journal: Cancer biology & medicine
Published: July 21, 2026
The global clinical trial landscape of PD-1-containing bispecific antibodies for gastric cancer: current status and future directions of targeting immune tolerance.
Journal: Frontiers in immunology
Published: April 27, 2026
Single Nucleotide Polymorphisms within the microRNA Binding Site of SET8 Modify Ankylosing Spondylitis Risk.
Journal: Genetic testing and molecular biomarkers
Published: November 13, 2025
Tislelizumab-induced hemophagocytic lymphohistiocytosis in a patient with microsatellite instability-high colon cancer and coexisting systemic lupus erythematosus: a case report and literature review.
Journal: Frontiers in oncology
Published: February 28, 2025
Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway.
Journal: Clinical Medicine Insights. Oncology
Published: November 21, 2022
Polymorphisms in microRNA binding site of SET8 regulate the risk of rheumatoid arthritis.
Journal: Experimental and therapeutic medicine
Published: November 21, 2022
Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
Journal: BMC cancer
Published: May 19, 2022
Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway.
Journal: Journal of hepatocellular carcinoma
Published: July 05, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026